168 related articles for article (PubMed ID: 14570405)
1. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes.
Ribeiro JA; Lobo MG; Sebastião AM
Neurochem Res; 2003 Oct; 28(10):1591-5. PubMed ID: 14570405
[TBL] [Abstract][Full Text] [Related]
2. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
Correia-de-Sá P; Ribeiro JA
Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
[TBL] [Abstract][Full Text] [Related]
3. Effects of allopurinol, erythro-9-(2-hydroxy-3-nonyl)adenine and S-(4-nitrobenzyl)-6-thioinosine on the degradation of adenosine 5'-triphosphate in the rat colon muscularis mucosae.
Tennant JP; Callaghan F; Turner C; Hourani SM
J Auton Pharmacol; 1999 Aug; 19(4):229-32. PubMed ID: 10589973
[TBL] [Abstract][Full Text] [Related]
4. Postischemic cardiac function recovery in the isolated rat heart: effects of adenosine deaminase and nucleoside transport inhibition.
Keeling IM; Obermayr RP; Schneider B; Spieckermann PG
Langenbecks Arch Surg; 2000 Dec; 385(8):531-7. PubMed ID: 11201010
[TBL] [Abstract][Full Text] [Related]
5. Extracellular metabolism of adenine nucleotides and adenosine in the innervated skeletal muscle of the frog.
Cunha RA; Sebastião AM
Eur J Pharmacol; 1991 May; 197(1):83-92. PubMed ID: 1654262
[TBL] [Abstract][Full Text] [Related]
6. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
7. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
[TBL] [Abstract][Full Text] [Related]
8. Separation between ischemic and reperfusion injury by site specific entrapment of endogenous adenosine and inosine using NBMPR and EHNA.
Abd-Elfattah AS; Wechsler AS
J Card Surg; 1994 May; 9(3 Suppl):387-96. PubMed ID: 8069025
[TBL] [Abstract][Full Text] [Related]
9. Effects of forskolin, dibutyryl cyclic AMP, and 5'-N-ethylcarboxamide adenosine on 22Na uptake by rat brain synaptosomes stimulated by veratridine.
Lobo MG; Ribeiro JA
J Neurochem; 1992 Mar; 58(3):1033-7. PubMed ID: 1310716
[TBL] [Abstract][Full Text] [Related]
10. Adenosine transport by rat and guinea pig synaptosomes: basis for differential sensitivity to transport inhibitors.
Shank RP; Baldy WJ
J Neurochem; 1990 Aug; 55(2):541-50. PubMed ID: 2370550
[TBL] [Abstract][Full Text] [Related]
11. N6-cyclohexyladenosine inhibits veratridine-stimulated 22Na uptake by rat brain synaptosomes.
Simões AP; Oliveira PC; Sebastião AM; Ribeiro JA
J Neurochem; 1988 Mar; 50(3):899-903. PubMed ID: 3339363
[TBL] [Abstract][Full Text] [Related]
12. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
Franco R; Hoyle CH; Centelles JJ; Burnstock G
Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
Singhal D; Anderson BD
J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
[TBL] [Abstract][Full Text] [Related]
15. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
[TBL] [Abstract][Full Text] [Related]
16. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-mediated cardiovascular toxicity in amitriptyline-poisoned rats.
Kalkan S; Hocaoglu N; Oransay K; Buyukdeligoz M; Tuncok Y
Drug Chem Toxicol; 2012 Oct; 35(4):423-31. PubMed ID: 22168308
[TBL] [Abstract][Full Text] [Related]
18. The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.
Kayhan N; Funke B; Conzelmann LO; Winkler H; Hofer S; Steppan J; Schmidt H; Bardenheuer H; Vahl CF; Weigand MA
Crit Care; 2008; 12(5):R125. PubMed ID: 18847498
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
Porter DJ; Abushanab E
Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
[TBL] [Abstract][Full Text] [Related]
20. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
